Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 15,254 | 0 | 0 | 0 | 0 |
| Cost of Goods | 8,428 | N/A | N/A | N/A | N/A |
| Gross Profit | 6,826 | N/A | N/A | N/A | N/A |
| Operating Expenses | 7,286 | 43 | 56 | 62 | 0 |
| Operating Income | -32 | -43 | -56 | -62 | N/A |
| Interest Expense | 439 | 0 | 0 | 0 | 0 |
| Other Income | 55 | 0 | -2 | -2 | 0 |
| Pre-tax Income | -416 | -43 | -58 | -64 | 0 |
| Income Tax | -96 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -320 | -43 | -58 | -63 | N/A |
| Minority Interests | N/A | 1 | 1 | N/A | N/A |
| Net Income | $-320 | $-44 | $-54 | $-59 | $N/A |
| EPS Basic Total Ops | -0.12 | -0.12 | -0.12 | -0.24 | N/A |
| EPS Basic Continuous Ops | -0.09 | -0.14 | -0.19 | -0.22 | N/A |
| EPS Diluted Total Ops | -0.12 | -0.12 | -0.12 | -0.24 | N/A |
| EPS Diluted Continuous Ops | -0.09 | -0.14 | -0.19 | -0.22 | N/A |
| EBITDA(a) | $408 | $-43 | $-56 | $-62 | $N/A |